Nitto Denko

Bend Labs, Inc. is a company that develops and manufactures integrated motion measurement systems aimed at remote healthcare. Based in Salt Lake City, Utah, Bend Labs specializes in a wearable soft sensor platform that accurately measures human motion. Notable products include the Smart Knee, a device equipped with integrated sensors and low-energy Bluetooth, designed to track knee usage and complex movements in real time. The company's technology encompasses a range of bending, stretching, and pressure sensors, along with an Android app and API that connect to its platform via Bluetooth. Founded in 2013, Bend Labs focuses on enabling sensor integration by collaborating with companies during the prototyping phase and facilitating large-scale commercial manufacturing and licensing. Its innovative soft silicone sensor technology is expected to play a crucial role in the development of smart garments, virtual reality gloves, and remote medical devices in the coming years.

C3Nano develops solution-based transparent conductive inks and films that replace indium tin oxide in touch sensors and displays. Its inks and films include transparent conductor films and silver nanowire inks that offer optical clarity, durability, and scratch resistance across substrates and processing methods, enabling flexible touch sensor and display applications. The company is headquartered in Silicon Valley with manufacturing in Korea and was founded in 2010.

Algotochip specializes in the development of digital chips, particularly Systems on a Chip (SOCs), by streamlining the design process. The company employs innovative technology to partition customer C-code into optimized modules, which facilitates the generation of necessary hardware and software components for complete application solutions. By transforming behavioral algorithms into Architecture C-code and further into RTL and GDS-II formats, Algotochip significantly reduces both the time and cost associated with chip design, making advanced digital solutions more accessible and efficient for clients.

Altea Therapeutics Corporation develops and commercializes transdermal drug delivery systems. It offers PassPort patch, a skin patch that uses short bursts of focused thermal energy to create tiny channels in the surface of the skin and these channels permit the flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. The company also provides Transdermal vaccine patch, a delivery system for water-soluble drugs and proteins; disease prevention products; insulin skin patch, a non-injectable daily insulin product; and opioid patches that provide delivery of opioids and incorporates the layers of deterrents. Altea Therapeutics Corporation was formerly known as Altea Development Corporation. The company was founded in 1998 and is based in Atlanta, Georgia. As of May 9, 2012, Altea Therapeutics Corporation operates as a subsidiary of Nitto Denko Corp.

Avecia is a prominent private biotechnology company that specializes in the development and manufacture of innovative biotechnology-based medicines through its OligoMedicines division. The company has a strong history of technological innovation and collaborates closely with biotechnology and pharmaceutical clients. Avecia's focus is on facilitating rapid advancement for these clients as they navigate the clinical development process, ensuring that their products progress efficiently from conception to clinical trials.